IL16 and myeloid sarcoma: Interestingly, in MS patient brain and spinal cords, IL-16 expression correlated with CD4 + Th1 inflammation and phosphorylation of axonal cytoskeleton in inflammatory lesions [73] with immunoreactivity confined to infiltrating mononuclear cells [73].